Back to the future: proceedings from the 2010 NF Conference.

  title={Back to the future: proceedings from the 2010 NF Conference.},
  author={Susan Mary Huson and Maria Teresa Acosta and Allan J. Belzberg and Andre Bernards and Jonathan Chernoff and Karen Cichowski and D. Gareth Evans and Rosalie E. Ferner and Marco Giovannini and Bruce R Korf and Robert H. Listernick and Kathryn N North and Roger J. Packer and Luis F. Parada and Juha M. Peltonen and V Ramakrishnan Ramesh and Karlyne M. Reilly and John W Risner and Elizabeth K. Schorry and Meena Upadhyaya and David Viskochil and Yuan Zhu and Kim Hunter-Schaedle and Filippo G. Giancotti},
  journal={American journal of medical genetics. Part A},
  volume={155A 2},
The neurofibromatoses (NF) encompass the rare diseases NF1, NF2, and schwannomatosis. The NFs affect 100,000 Americans; over 2 million persons worldwide; and are caused by mutation of tumor suppressor genes. Individuals with NF1 in particular may develop tumors anywhere in the nervous system; additional manifestations can include learning disabilities, bone dysplasia, cardiovascular defects, unmanageable pain, and physical disfigurement. Ultimately, the NFs can cause blindness, deafness, severe… CONTINUE READING